Abstract
We examined the clinical features and therapeutic response of a group of patients with acute leukemia and hypocellular bone marrow. Therapists have generally avoided, delayed or modified therapy because of hypocellularity. We demonstrated not only that aggressive therapy is possible, but also that the remission rate is high (complete remission = 73 percent) and survival prolonged (x̄ > 40 months).
Original language | English (US) |
---|---|
Pages (from-to) | 391-395 |
Number of pages | 5 |
Journal | The American Journal of Medicine |
Volume | 72 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1982 |